Billionaire Dan Loeb trims position in Herbalife

He's one of three tycoons fighting over the stock. Intrigue around the multi-level marketer continues.

By Jonathan Berr Feb 18, 2013 1:09PM
Credit: Tiffany Rose/WireImage/Getty Images
Caption: Herbalife product at the Nautica Malibu TriathlonBillionaire Daniel Loeb, one of three hedge-fund tycoons at the center of the drama around Herbalife (HLF), has trimmed his position in the multi-level marketer.

According to CNBC, Loeb, who runs the Third Point fund, started unloading shares in the seller of nutritional supplements and personal-care products a few weeks ago. 

The business news channel didn't have specifics on the sale, though it did mention that Loeb hasn't liquidated its take in the Cayman Islands company entirely. Loeb's other noteworthy positions include Yahoo (YHOO), where he is a member of the board.

Shares of Herbalife are up almost 18% since the start of the year, so Loeb's move may be simple profit-taking. After all, hedge funds are constantly trading around their positions to maximize returns. But Herbalife is not a typical stock.

Herbalife has been clouded in controversy for years and has long been a favorite target of short sellers. More than 32% of Herbalife's float is currently held by investors betting the shares will fall, according to The Wall Street Journal. Hedge-fund manager Bill Ackman has called Herbalife a "Ponzi scheme" and predicted that the company's shares will hit zero.

Loeb took a long position in Herbalife to counter Ackman's $1 billion short position. Carl Icahn, another billionaire, recently revealed a 13% stake in Herbalife. And though Icahn and Ackman made headlines with an insult-filled argument on live television, Icahn he insists that his investment has nothing to do with the animosity he feels toward his rival. 

Herbalife has repeatedly denied that is business practices are improper.

--Jonathan Berr does not own shares of the listed stocks. Follow him on Twitter @jdberr.


More on moneyNOW




1Comment
Feb 18, 2013 4:17PM
avatar
herbie life and it's anthony powell dominated "sales" philosophy and structure - hmm, maybe they both need to be sued into oblivion........
Report
Please help us to maintain a healthy and vibrant community by reporting any illegal or inappropriate behavior. If you believe a message violates theCode of Conductplease use this form to notify the moderators. They will investigate your report and take appropriate action. If necessary, they report all illegal activity to the proper authorities.
Categories
100 character limit
Are you sure you want to delete this comment?

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

Trending NOW

What’s this?

About moneyNOW

moneyNOW brings users smart, original and entertaining takes on the latest business and investing topics that are buzzing on the web.

MARKET UPDATE

[BRIEFING.COM] Stocks ended modestly higher as the S&P 500 climbed 0.2%, and the Dow added 0.4% to register its 19th consecutive Tuesday of gains.

The major averages saw little change during morning action, but afternoon buying interest helped lift the indices to session highs. Most cyclical sectors (with the exception of materials and technology) finished among the leaders, but the defensively-geared health care sector settled atop the leaderboard as biotechnology outperformed. ... More

MSN MONEY'S